{"id":1799,"date":"2022-01-04T13:08:54","date_gmt":"2022-01-04T13:08:54","guid":{"rendered":"https:\/\/govorimoorakupluca.com\/?page_id=1799"},"modified":"2022-01-04T13:59:18","modified_gmt":"2022-01-04T13:59:18","slug":"pametni-lijekovi","status":"publish","type":"page","link":"https:\/\/2023.govorimoorakupluca.com\/en\/lijecenje-raka-pluca\/pametni-lijekovi\/","title":{"rendered":"Pametni lijekovi"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"1799\" data-post-id=\"1799\" data-obj-id=\"1799\" class=\"elementor elementor-1799 dce-elementor-post-1799\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-bf3f8bb elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"bf3f8bb\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-b653ac4\" data-id=\"b653ac4\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-d2bda1b elementor-widget elementor-widget-heading\" data-id=\"d2bda1b\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Ciljana terapija ili \u201epametni lijekovi\u201c<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-36a5bca elementor-widget elementor-widget-text-editor\" data-id=\"36a5bca\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Ciljana terapija (targetirana terapija) ili terapija tzv. \u201epametnim lijekovima\u201c vrsta je lije\u010denja koja se primjenjuje kod bolesnika s rakom plu\u0107a nemalih stanica tek ne\u0161to vi\u0161e od desetlje\u0107a. Najbitnija\u00a0 karakteristika ove vrste terapije je selektivnost prema odre\u0111enim tumorskim stanicama po \u010demu je ova skupina lijekova i dobila ime.<\/p><p>Ciljana terapija ima antitumorski u\u010dinak kod onih (pod)vrsta tumora koji na\/u svojim stanicama imaju specifi\u010dna obilje\u017eja (naj\u010de\u0161\u0107e na membranama) koja uvjetuju tumorska obilje\u017eja stanica. Stoga se \u201epametni lijekovi\u201c naj\u010de\u0161\u0107e ve\u017eu na promijenjene dijelove te biomembrane. Oniodre\u0111enim mehanizmima zaustavljaju rast i diobu tumorskih stanica.U klini\u010dkoj praksi se taj u\u010dinak vidi kao smanjivanje i\/ili nestanak tumora.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-156a386 elementor-reverse-tablet elementor-reverse-mobile elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"156a386\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-2613831\" data-id=\"2613831\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-6ae6d77 elementor-widget elementor-widget-text-editor\" data-id=\"6ae6d77\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Ove vrste terapija se u svakodnevnoj klini\u010dkoj praksiprimjenjuju kod raka plu\u0107a ne-malih stanica koji imaju pozitivne mutacije receptora za epidermalni \u010dimbenik rasta (EGFR) ili promjene ALK ili ROS1. Sve je vi\u0161e novih obilje\u017eja koje je mogu\u0107e otkriti novim dijagnosti\u010dkim metodama, a na koje neke nove molekule imaju antitumorski u\u010dinak.<\/p><p>Problem lije\u010denja ciljanom terapijom jest \u010dinjenica da nakon odre\u0111enog perioda lije\u010denja (vi\u0161e mjeseci ili vi\u0161e godina) dolazi do razvoja rezistencije i ponovnog rasta tumora. Tada je potrebno promijeniti vrstu lije\u010denja, bilo novom ciljanom terapijom ili nekom drugom dostupnom i u\u010dinkovitom opcijom. Kao svaka vrsta specifi\u010dnog onkolo\u0161kog lije\u010denja i ova terapija, iako se uglavnom odli\u010dno podnosi, mo\u017ee uzrokovati i mogu\u0107e ne\u017eeljene nuspojave. One se uglavnom vrlo jednostavno mogu kontrolirati, ali ih je va\u017eno prepoznati i na vrijeme lije\u010diti.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Ciljana terapija ili \u201epametni lijekovi\u201c Ciljana terapija (targetirana terapija) ili terapija tzv. \u201epametnim lijekovima\u201c vrsta je lije\u010denja koja se primjenjuje kod bolesnika s rakom plu\u0107a nemalih stanica tek ne\u0161to vi\u0161e od desetlje\u0107a. Najbitnija\u00a0 karakteristika ove vrste terapije je selektivnost prema odre\u0111enim tumorskim stanicama po \u010demu je ova skupina lijekova i dobila ime. Ciljana terapija ima [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":1761,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-1799","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/2023.govorimoorakupluca.com\/en\/wp-json\/wp\/v2\/pages\/1799","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/2023.govorimoorakupluca.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/2023.govorimoorakupluca.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/2023.govorimoorakupluca.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/2023.govorimoorakupluca.com\/en\/wp-json\/wp\/v2\/comments?post=1799"}],"version-history":[{"count":6,"href":"https:\/\/2023.govorimoorakupluca.com\/en\/wp-json\/wp\/v2\/pages\/1799\/revisions"}],"predecessor-version":[{"id":1839,"href":"https:\/\/2023.govorimoorakupluca.com\/en\/wp-json\/wp\/v2\/pages\/1799\/revisions\/1839"}],"up":[{"embeddable":true,"href":"https:\/\/2023.govorimoorakupluca.com\/en\/wp-json\/wp\/v2\/pages\/1761"}],"wp:attachment":[{"href":"https:\/\/2023.govorimoorakupluca.com\/en\/wp-json\/wp\/v2\/media?parent=1799"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}